85 related articles for article (PubMed ID: 8654769)
1. Breast cancer-associated antibody LU BCRU G7 recognises the terminal disaccharide Gal beta 1-3GlcNAc and can be used to isolate tumour cells from body fluids by an immunomagnetic bead procedure.
Rye PD; Bovin NV; Vlasova E; Høifødt HK; Kierulf B; Trones GE; Fodstad O
Biochem Soc Trans; 1995 Nov; 23(4):584S. PubMed ID: 8654769
[No Abstract] [Full Text] [Related]
2. Monoclonal antibody LU-BCRU-G7 against a breast tumour-associated glycoprotein recognizes the disaccharide Gal beta 1-3GlcNAc.
Rye PD; Bovin NV; Vlasova EV; Walker RA
Glycobiology; 1995 Jun; 5(4):385-9. PubMed ID: 7579792
[TBL] [Abstract][Full Text] [Related]
3. The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detection.
Hager G; Cacsire-Castillo Tong D; Schiebel I; Rezniczek GA; Watrowski R; Speiser P; Zeillinger R
Gynecol Oncol; 2005 Aug; 98(2):211-6. PubMed ID: 15967487
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of a breast cancer-associated glycoprotein detected by monoclonal antibody LU-BCRU-G7.
Rye PD; Walker RA
Eur J Cancer; 1994; 30A(7):1007-12. PubMed ID: 7946564
[TBL] [Abstract][Full Text] [Related]
5. Selection of carbohydrate-binding cell phenotypes using oligosaccharide-coated magnetic particles.
Rye PD; Bovin NV
Glycobiology; 1997 Mar; 7(2):179-82. PubMed ID: 9134424
[TBL] [Abstract][Full Text] [Related]
6. Breast carcinoma specific antibody selection combining phage display and immunomagnetic cell sorting.
Mazuet C; Lerouge D; Poul MA; Blin N
Biochem Biophys Res Commun; 2006 Sep; 348(2):550-9. PubMed ID: 16890194
[TBL] [Abstract][Full Text] [Related]
7. Breast tumor contamination of peripheral blood stem cell harvests: increased sensitivity of detection using immunomagnetic enrichment.
Umiel T; Prilutskaya M; Nguyen NH; Moss TJ; Schaeffer A; Burgess J; Griffith M; Mills B
J Hematother Stem Cell Res; 2000 Dec; 9(6):895-904. PubMed ID: 11177603
[TBL] [Abstract][Full Text] [Related]
8. Effects of target antigen density on the efficacy of immunomagnetic cell separation.
Gee AP; Mansour VH; Weiler MB
J Immunol Methods; 1991 Aug; 142(1):127-36. PubMed ID: 1717593
[TBL] [Abstract][Full Text] [Related]
9. Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS) for molecular profiling.
Magbanua MJ; Park JW
Methods; 2013 Dec; 64(2):114-8. PubMed ID: 23896286
[TBL] [Abstract][Full Text] [Related]
10. Characterization of two monoclonal antibodies specific for lacto-series type 1 chain Gal beta 1----3GlcNAc-terminal structures.
Holmes EH; Greene TG
Arch Biochem Biophys; 1990 Feb; 277(1):181-8. PubMed ID: 2306119
[TBL] [Abstract][Full Text] [Related]
11. Characterization of antibody binding to three cancer-related antigens using flow cytometry and cell tracking velocimetry.
Chosy EJ; Nakamura M; Melnik K; Comella K; Lasky LC; Zborowski M; Chalmers JJ
Biotechnol Bioeng; 2003 May; 82(3):340-51. PubMed ID: 12599261
[TBL] [Abstract][Full Text] [Related]
12. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Ca 1 antibody in the diagnosis of invasive breast cancer.
Clough DG; Coghill GR; Holley MP
J Clin Pathol; 1984 Jan; 37(1):10-3. PubMed ID: 6368594
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads.
Vredenburgh JJ; Simpson W; Memoli VA; Ball ED
Cancer Res; 1991 May; 51(9):2451-5. PubMed ID: 1673088
[TBL] [Abstract][Full Text] [Related]
15. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
16. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
Woelfle U; Breit E; Zafrakas K; Otte M; Schubert F; Müller V; Izbicki JR; Löning T; Pantel K
J Immunol Methods; 2005 May; 300(1-2):136-45. PubMed ID: 15907331
[TBL] [Abstract][Full Text] [Related]
17. MCA, a monoclonal-antibody-defined breast-tumor-associated antigen and its relation to CA 15.3.
Bieglmayer C; Szepesi T; Neunteufel W; Nowotny C
Tumour Biol; 1989; 10(5):232-42. PubMed ID: 2814232
[TBL] [Abstract][Full Text] [Related]
18. Isotype-directed enrichment of B cells by magnetic beads in the generation of immunoreactive human monoclonal antibodies.
McKnight ME; Mukerjee S; Nasoff M; Gaskins C; Glassy MC
Hybridoma; 1996 Aug; 15(4):255-61. PubMed ID: 8880212
[TBL] [Abstract][Full Text] [Related]
19. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
Han X; Shi Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of monoclonal antibody to T-antigen: (gal beta1-3GalNAc-alpha-O).
Rittenhouse-Diakun K; Xia Z; Pickhardt D; Morey S; Baek MG; Roy R
Hybridoma; 1998 Apr; 17(2):165-73. PubMed ID: 9627057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
